Podcast | Digital Health and Innovation | June 12, 2020

Testing for COVID-19: Perspective from Abbott, Industry Leader in Infectious Disease Testing

In the podcast, we are joined with 2 executives from Abbot that is an industry leader in testing of infectious diseases. The goal of this podcast is to provide an overview of COVID-19 testing. We will further discuss current challenges and misconceptions related to quality and availability of tests. Lastly we will discuss the importance of serology testing and managing high risk populations.

John Hackett
John Hackett is divisional vice president of Applied Research and Technology for Abbott’s diagnostics business. In this role, he manages diagnostics R&D in the areas of infectious diseases, oncology, cardiovascular, metabolic biologics design and discovery, and clinical chemistry.

John is responsible for managing Abbott’s Global Viral Surveillance Program, which was established more than two decades ago to detect and actively monitor emerging HIV and hepatitis strains around the world. The Surveillance Program houses more than 78,000 samples containing HIV and hepatitis viruses, making it one of the largest libraries in the world. If a new strain is discovered, Abbott’s scientists check that the current blood screening and diagnostic tests can detect it.
Learn More About John

Jeremy Schubert
Divisional Vice President, USO Commercial Operations
Abbott Diagnostics Division

Jeremy has dedicated his entire professional career to Abbott joining in 1993.  He has held several commercial and leadership positions across multiple divisions of Abbott, including Managing Director for Northern Europe and Divisional Vice President of Latin America and Canada.  Jeremy assumed his current role as Divisional Vice President for US ADD Commercial Operations in 2017.
Learn More About Jeremy

Deepak Mohan, MD
Dr. Deepak Mohan is a pathologist in French Camp, CA. and is affiliated with San Joaquin General Hospital. He specializes in anatomic and clinical pathology and has been in practice for 16 years.

He received his medical degree from Sri Ramachandra Medical College and completed his Anatomic and Clinical Pathology Residency at University of Pittsburgh Medical Center and his Surgical Pathology Fellowship at Cedars-Sinai Medical Center, Los Angeles, CA.

Andy Mohan, MD, MBA, MSc
Dr. Anand “Andy” Mohan has been working as a physician informaticist and Healthcare IT executive for over 10 years.  He has worked on the inpatient and ambulatory side with all specialties throughout the lifecycle of an EHR implementation. His focus is on clinical workflow optimization, utilizing EHR systems efficiently, provider adoption, and population health initiative technology implementations.

Learn More About Andy

 

References and Resources

  1. Chandrashekar et al., Science 10.1126/science.abc4776 (2020).
  2. Bryan A, et al. J Clin Microbiol. (2020) ;JCM.00941-20. doi:10.1128/JCM.00941-20
  3. Ng D, Goldgof G, Shy B, et al. Preprint. medRxiv. 2020;2020.05.19.20107482. Published 2020 May 25. doi:10.1101/2020.05.19.20107482